We are live on
!
Find out more
GA
GuoLine Advisory Portfolio holdings
AUM
$1.07B
1-Year Est. Return
26.27%
This Fund
S&P 500
This Quarter
Est. Return
+23.05%
1 Year Est. Return
+26.27%
3 Year Est. Return
+81.88%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$356M
AUM Growth
–
Cap. Flow
+$327M
Cap. Flow
% of AUM
91.88%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
8
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$50.7M |
| 2 |
GE Aerospace
GE
|
+$50.3M |
| 3 |
Microsoft
MSFT
|
+$49.6M |
| 4 |
Apple
AAPL
|
+$45M |
| 5 |
GE HealthCare
GEHC
|
+$38.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.88% |
| 2 | Healthcare | 27.02% |
| 3 | Financials | 16.61% |
| 4 | Industrials | 16.13% |
| 5 | Communication Services | 10.36% |
Similar funds
SCM
PP
DCP
ZIG
EC
FNT
TAM
EG
GuoLine Advisory's Q1 2023 Portfolio in Review
Q1 2023 is the first quarter with a 13F filing on record for GuoLine Advisory, which disclosed 8 positions worth $356M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Thermo Fisher Scientific: 90,000 shares worth $51.9M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, followed by Healthcare and Financials.
- GuoLine Advisory's largest Q1 2023 buy was Thermo Fisher Scientific: 90,000 shares worth $51.9M.
- GuoLine Advisory's ten largest holdings make up 100% of its $356M portfolio in Q1 2023.
- GuoLine Advisory disclosed 8 positions in Q1 2023, its first 13F filing on record.
Based on GuoLine Advisory's 13F filing for Q1 2023, filed 24 Apr 2023.